参考文献/References:
[1]秦岭,邱志锋,谢静,等.系统性红斑狼疮合并机会性感染的疾病谱及其外周血淋巴细胞亚群特点分析[J].中华内科杂志,2018,57(1):32-36.[2]侯成成,金欧,张曦,等.系统性红斑狼疮患者合并感染的临床特点及危险因素分析[J].新医学,2015,46(11):743-747.[3]李志,杨婷婷,李文哲,等.系统性红斑狼疮患者外周血Th17与Treg细胞及相关细胞因子表达的研究[J].中国实验诊断学,2015,19(2):253-255.[4]Rodriguez-Hernandez A,Ortiz-Orendain J,Alvarez-Palazuelos LE,et al.Seizures in systemic lupus erythematosus: A scoping review[J].Seizure,2021(86):161-167.[5]Borgia R,Gerstein M,Levy D,et al.Features,treatment,and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus[J].Arthritis Rheumatol,2018,70(4):616-624.[6]王秀娇,左晓霞,谢晓韵,等.系统性红斑狼疮住院患者合并严重感染的危险因素[J].中南大学学报(医学版),2021,46(7):704-710.[7]蔡君,徐蓉.系统性红斑狼疮细菌感染影响因素分析[J].中华医院感染学杂志,2019,29(24):3773-3776.[8]Dhital R,Pandey RK,Poudel DR,et al.All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database[J].Rheumatology International,2020,40(3):393-397.[9]王川颖,单葵,胡芳君.系统性红斑狼疮合并深部真菌感染影响因素分析[J].中华医院感染学杂志,2019,29(14):2130-2133.[10]李双一,牛林,李兴,等.淋巴细胞及T细胞亚群与系统性红斑狼疮是否合并感染的关系[J].湖南师范大学学报(医学版),2021,18(2):206-209.[11]Merayo-Chalico J,Rajme-López S,Barrera-Vargas A,et al.Lymphopenia and autoimmunity: A double-edged sword[J].Hum Immunol,2016,77(10):921-929.[12]Moulton VR,Suarez-Fueyo A,Meidan E,et al.Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective[J].Trends in Molecular Medicine,2017,23(7):615-635.[13]罗伟,张壮苗,邓黎黎,等.老年系统性红斑狼疮患者合并感染与Th1/Th2细胞因子谱的关系[J].中国老年学杂志,2020,40(19):4164-4167.[14]Natascha K,Vogelmann M,Spring B,et al.Granulocytic myeloid derivedsuppressor cells from human cord blood modulate T-helper-cellresponse towards an anti-inflammatory phenotype [J].Immunology,2017,152(1):89-101.[15]刘怡,谭静雅,卿红梅,等.系统性红斑狼疮患者外周血T淋巴细胞亚群和亲环素A的表达及临床意义[J].分子诊断与治疗杂志,2021,13(6):885-888,892.[16]Wu L,Wang X,Chen F,et al.T cellsubsets and immunoglobulin G levels are associated withthe infection status of systemic lupus erythematosus patients[J].Braz J Med Biol Res,2018,51(2):e4547.[17]常婷婷,邢丽华.系统性红斑狼疮合并肺部感染患者T淋巴细胞亚群的研究[J].河南医学研究,2016,25(4):597-599.[18]谭雨亭,侍效春,刘晓清,等.系统性红斑狼疮合并巨细胞病毒感染的临床特征及危险因素[J].中国医学科学院学报,2020,42(6):749-754.[19]Lin H,Wei JC,Tan CY,et al.Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China[J].Clin Rheumatol,2012,31(12):1683-1689.[20]孙鹏,刘尧,胡劲辉,等.补体C3与C4和IL-23在系统性红斑狼疮患者感染诊断中的价值[J].中华医院感染学杂志,2019,29(4):570-573.[21]毛洪博,孟凡杰,谭婷婷.血清抗bFGF自身抗体在活动期自身免疫性疾病中的检测价值分析[J].河北医学,2020,26(2):338-342.[22]徐晋豫.狼疮性肾炎患者免疫球蛋白、CD4+T细胞计数与SLEDAI评分的相关性分析[J].慢性病学杂志,2021,22(7):1107-1109.[23]Ng WL,Chu CM,Wu AK,et al.Lymphopenia at presentation is associated with increased risk ofinfections in patients with systemic lupus erythematosus[J].QJM,2006,99(1):37-47.[24]Santamaría-Alza Y,Sánchez-Bautista J,Fajardo-Rivero JF,et al.Invasive fungal infections in Colombian patients with systemic lupus erythematosus[J].Lupus,2018,27(7):1116-1122.[25]Torres-Ruiz J,Mejía-Domínguez NR,Zentella-Dehesa A,et al.The Systemic Lupus Erythematosus Infection Predictive Index (LIPI):A Clinical-Immunological Tool to Predict Infections in Lupus Patients[J].Front Immunol,2019(9):3144.[26]Katsuyama T,Martin-Delgado IJ,Krishfield SM,et al.Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus[J].Rheumatology (Oxford),2020,59(8):2146-2155.[27]李鎛江,肖友文,董建华,等.NLR、C3、C4、CRP评估系统性红斑狼疮疾病活动度的比较分析[J].现代临床医学,2021,47(5):321-324.[28]罗东萍.超敏C反应蛋白在系统性红斑狼疮中的应用[J].山西医科大学学报,2016,47(12):1101-1103.[29]唐仕超,王赓,张志国,等.补体C3、补体C4和C反应蛋白在系统性红斑狼疮活动和感染中的临床价值[J].第二军医大学学报,2016,37(4):397-400.
相似文献/References:
[1]贾海英,黄睿,王玲玲,等.多发性骨髓瘤患者淋巴细胞亚群变化对免疫功能的影响研究[J].医学信息,2018,31(01):147.[doi:10.3969/j.issn.1006-1959.2018.01.057]
JIA Hai-ying,HUANG Rui,WANG Ling-ling,et al.The Effect of Lymphocyte Subgroup Changes on Immune Function in Patients with Multiple Myeloma[J].Medical Information,2018,31(04):147.[doi:10.3969/j.issn.1006-1959.2018.01.057]
[2]吴 霞,肖盼盼,谢晓然,等.qRT-PCR法分析复发性SLE患者肠道双歧杆菌、
柔嫩梭菌数量的变化[J].医学信息,2018,31(05):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
WU Xia,XIAO Pan-pan,XIE Xiao-ran,et al.Analysis of the Changes of Intestinal Bifidobacterium and Clostridium Tenella in Patients with Recurrent SLE by qRT-PCR[J].Medical Information,2018,31(04):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
[3]甘红婉,肖德俊,曾 瑜,等.奥洛他定联合匹多莫德治疗慢性荨麻疹的疗效及对外周血淋巴细胞亚群影响[J].医学信息,2018,31(21):144.[doi:10.3969/j.issn.1006-1959.2018.21.041]
GAN Hong-wan,XIAO De-jun,ZENG Yu,et al.Efficacy of Olopatadine Combined with Pidotimod in the Treatment of Chronic Urticaria and Its Effect on Peripheral Blood Lymphocyte Subsets[J].Medical Information,2018,31(04):144.[doi:10.3969/j.issn.1006-1959.2018.21.041]
[4]屈佳琪,李 洋.核酸传感器与CD72在系统性红斑狼疮中的作用[J].医学信息,2019,32(14):49.[doi:10.3969/j.issn.1006-1959.2019.14.017]
QU Jia-qi,LI Yang.The Role of Nucleic Acid Sensors and CD72 in Systemic Lupus Erythematosus[J].Medical Information,2019,32(04):49.[doi:10.3969/j.issn.1006-1959.2019.14.017]
[5]陈汉白,赵之婧,罗希莹,等.系统性红斑狼疮治疗领域文献的大数据分析[J].医学信息,2019,32(23):1.[doi:10.3969/j.issn.1006-1959.2019.23.001]
CHEN Han-bai,ZHAO Zhi-jing,LUO Xi-ying,et al.Big Data Analysis of Literature in the Field of Systemic Lupus Erythematosus Treatment[J].Medical Information,2019,32(04):1.[doi:10.3969/j.issn.1006-1959.2019.23.001]
[6]白巧红.系统性红斑狼疮合并感染的临床特点[J].医学信息,2019,32(23):86.[doi:10.3969/j.issn.1006-1959.2019.23.023]
BAI Qiao-hong.Clinical Features of Systemic Lupus Erythematosus Infection[J].Medical Information,2019,32(04):86.[doi:10.3969/j.issn.1006-1959.2019.23.023]
[7]徐 莹,薛国辉,华 琳.系统性红斑狼疮患者中TAFI、PAI-1及t-PA水平变化及其与疾病活动度的关系[J].医学信息,2020,33(20):54.[doi:10.3969/j.issn.1006-1959.2020.20.015]
XU Ying,XUE Guo-hui,HUA Lin.Changes of TAFI,PAI-1 and t-PA Levels in Patients with Systemic Lupus Erythematosus and Their Relationship with Disease Activity[J].Medical Information,2020,33(04):54.[doi:10.3969/j.issn.1006-1959.2020.20.015]
[8]王 娟,汪 奎,牛彩琴.贝利木单抗治疗系统性红斑狼疮的有效性和安全性的系统评价[J].医学信息,2021,34(21):65.[doi:10.3969/j.issn.1006-1959.2021.21.016]
WANG Juan,WANG Kui,NIU Cai-qin.System Analysis of the Efficacy and Safety of Belimumab in the Treatment of Systemic Lupus Erythematosus[J].Medical Information,2021,34(04):65.[doi:10.3969/j.issn.1006-1959.2021.21.016]
[9]皮玲玲.基于Medline数据库的国内风湿病发表论文的可视化分析[J].医学信息,2022,35(03):13.[doi:10.3969/j.issn.1006-1959.2022.03.003]
PI Ling-ling.Visual Analysis of Published Papers on Rheumatism in China Based on Medline Database[J].Medical Information,2022,35(04):13.[doi:10.3969/j.issn.1006-1959.2022.03.003]
[10]梁敏敏,邹光美,杨小兰,等.SAA、IL-6、C3、C4联合检测对SLE患者的诊断价值[J].医学信息,2024,37(14):96.[doi:10.3969/j.issn.1006-1959.2024.14.018]
LIANG Min-min,ZOU Guang-mei,YANG Xiao-lan,et al.Diagnostic Value of Combined Detection of SAA, IL-6, C3 and C4 in SLE Patients[J].Medical Information,2024,37(04):96.[doi:10.3969/j.issn.1006-1959.2024.14.018]